Thailand’s Weed Rewind: Puff Puff Pause
Thailand’s $1.2B cannabis market is reeling as 90% of dispensaries are shut down and the government moves to reclassify the plant as a narcotic. Some say it’s chaos—others call it a necessary reset.
Thailand’s $1.2B cannabis market is reeling as 90% of dispensaries are shut down and the government moves to reclassify the plant as a narcotic. Some say it’s chaos—others call it a necessary reset.
A new Bloomwell survey reveals 42% of German cannabis patients would return to illicit sources if digital access is restricted. With patient numbers up 1100% since reclassification, leaders warn that political rollbacks could reverse medical progress.
A new House GOP spending bill seeks to halt cannabis rescheduling, threatening federal reform progress even as support grows among Republicans and youth voters.
Florida’s adult-use cannabis campaign is gaining momentum, but a new law signed by Governor DeSantis revokes medical marijuana cards from patients with drug convictions—signaling a sharp crackdown even as legalization efforts ramp up for 2026.
Thailand has ended its brief era of cannabis decriminalization, banning recreational use and requiring medical prescriptions. The abrupt reversal shakes a $1.2B industry and sparks protests as political turmoil deepens and dispensaries face closures.
Czechia will legalize home cannabis cultivation and possession for adults 21+ starting January 1, 2026. The law allows up to 3 plants and 100g of flower, marking a major shift in European drug policy—though retail sales remain off the table for now.
TerrAscend expands into its sixth U.S. state with the acquisition of Ratio Cannabis in Ohio. The move adds a high-performing dispensary to its 39-location footprint and positions the company for growth ahead of the state's adult-use market launch.
Jeff Schultz, a former hedge fund attorney, has become a leading voice in cannabis law and policy. From shaping New York’s adult-use rollout to advising top brands, his journey reflects the power of passion, advocacy, and legal expertise in a shifting industry.
New York’s cannabis market hits new highs with 366 dispensaries, workforce training programs, and a statewide education campaign. OCM leads with equity, safety, and science to grow a smarter, more inclusive industry.
The U.S. legal cannabis market is projected to add $123.6 billion to the economy in 2025, despite stalled reform and rising costs. With New York and Ohio emerging and federal change on pause, the industry grows through uncertainty. What will it take to unlock its full potential?
Germany will maintain its cannabis legalization law despite conservative opposition, with a full policy review set for late 2025. Personal use and cultivation remain legal, while medical access and cannabis clubs continue under national guidelines.
The 2025 International Cannabis Business Conference (ICBC) in Berlin marks a decade of industry progress, spotlighting Germany’s landmark cannabis legalization. With Germany leading Europe in medical cannabis reform, ICBC serves as a key platform for global cannabis policy, business, and advocacy.
New York’s cannabis market is evolving with new legislation allowing the sale of intoxicating hemp products and opening doors for out-of-state brands. A new branding license will help cannabis companies enter the state’s legal market, bypassing traditional processing requirements.
New York Attorney General secures a $6 million judgment against Big Chief Smoke Shop, an unlicensed cannabis retailer. The shop faced penalties for selling illegal cannabis products, undermining the state's regulated market. This action reinforces New York's crackdown on illicit cannabis operations.
New York State has surpassed 300 licensed cannabis dispensaries, contributing to economic growth and job creation. With 80% of retail licenses awarded to Social and Economic Equity applicants, the legal cannabis market continues to expand access to safer, regulated products across the state.